Actively Recruiting
IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer
Led by State University of New York at Buffalo · Updated on 2025-10-31
450
Participants Needed
2
Research Sites
156 weeks
Total Duration
On this page
Sponsors
S
State University of New York at Buffalo
Lead Sponsor
T
Thomas Jefferson University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this research is to assess how patients with cancer being treated with Immune Checkpoint Inhibitors (ICI) manage symptoms related to cancer and/or its treatment. Patients use a variety of ways to manage symptoms including traditional and alternative treatments including cannabis, acupuncture, etc. This research will have an important impact on our knowledge of cancer symptom management, and ultimately improve patient care and safety. Participants will complete online surveys and 7 days of ecological momentary assessments at 0, 1, 2, 4, 6, 9 and 12 month to compare the cannabis users and non cannabis users symptoms.
CONDITIONS
Official Title
IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult age of 21 years or older
- Cancer diagnosis and planning or using immunotherapy treatment
- Experience pain but spend less than 50% of the day in bed or chair
- Fluent in English language
You will not qualify if you...
- Use synthetic cannabis or only use Cannabidiol (CBD)
- Non-users who used cannabis in the past 3 months
- Prior immunotherapy treatment
- Receiving immunosuppressants or organ transplant recipients
- Receiving hospice care within the past 6 months
- Pain limits movement to more than 50% of the day spent in bed or chair
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Oregon Health and Science University
Portland, Oregon, United States, 97239
Not Yet Recruiting
2
Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107
Actively Recruiting
Research Team
R
Rebecca L Ashare, PhD
CONTACT
C
Colleen K Kilanowski, MS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here